Day S - Search Results

1

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E. Gamble C, et al. Among authors: day s. JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556. JAMA. 2017. PMID: 29260229 Free article.

2

Progression-seeking bias and rational optimism in research and development.

Lendrem DW, Lendrem BC, Peck RW, Senn SC, Day S, Isaacs JD. Lendrem DW, et al. Among authors: day s. Nat Rev Drug Discov. 2015 Mar;14(3):219-21. doi: 10.1038/nrd4320-c1. Epub 2015 Feb 6. Nat Rev Drug Discov. 2015. PMID: 25656595 No abstract available.

3

Statistical reporting of clinical pharmacology research.

Ring A, Schall R, Loke YK, Day S. Ring A, et al. Among authors: day s. Br J Clin Pharmacol. 2017 Jun;83(6):1159-1162. doi: 10.1111/bcp.13254. Epub 2017 Mar 21. Br J Clin Pharmacol. 2017. PMID: 28321897 Free PMC article.

4

Recommendations for the design of small population clinical trials.

Day S, Jonker AH, Lau LPL, Hilgers RD, Irony I, Larsson K, Roes KC, Stallard N. Day S, et al. Orphanet J Rare Dis. 2018 Nov 6;13(1):195. doi: 10.1186/s13023-018-0931-2. Orphanet J Rare Dis. 2018. PMID: 30400970 Free PMC article.

5

Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov.

Hee SW, Willis A, Tudur Smith C, Day S, Miller F, Madan J, Posch M, Zohar S, Stallard N. Hee SW, et al. Among authors: day s. Orphanet J Rare Dis. 2017 Mar 2;12(1):44. doi: 10.1186/s13023-017-0597-1. Orphanet J Rare Dis. 2017. PMID: 28253932 Free PMC article.

6

Missing data handling in non-inferiority and equivalence trials: A systematic review.

Rabe BA, Day S, Fiero MH, Bell ML. Rabe BA, et al. Among authors: day s. Pharm Stat. 2018 Sep;17(5):477-488. doi: 10.1002/pst.1867. Epub 2018 May 25. Pharm Stat. 2018. PMID: 29797777

7

Approaches to sample size calculation for clinical trials in rare diseases.

Miller F, Zohar S, Stallard N, Madan J, Posch M, Hee SW, Pearce M, Vågerö M, Day S. Miller F, et al. Among authors: day s. Pharm Stat. 2018 May;17(3):214-230. doi: 10.1002/pst.1848. Epub 2018 Jan 10. Pharm Stat. 2018. PMID: 29322632

8

Decision-theoretic designs for small trials and pilot studies: A review.

Hee SW, Hamborg T, Day S, Madan J, Miller F, Posch M, Zohar S, Stallard N. Hee SW, et al. Among authors: day s. Stat Methods Med Res. 2016 Jun;25(3):1022-38. doi: 10.1177/0962280215588245. Epub 2015 Jun 5. Stat Methods Med Res. 2016. PMID: 26048902 Free PMC article. Review.

9

Improved Reporting in Abstracts When Uncertainty Is Inevitable.

Halabi S, Day S. Halabi S, et al. Among authors: day s. JAMA Netw Open. 2019 Dec 2;2(12):e1917543. doi: 10.1001/jamanetworkopen.2019.17543. JAMA Netw Open. 2019. PMID: 31834388 Free article. No abstract available.

10

Determination of the optimal sample size for a clinical trial accounting for the population size.

Stallard N, Miller F, Day S, Hee SW, Madan J, Zohar S, Posch M. Stallard N, et al. Among authors: day s. Biom J. 2017 Jul;59(4):609-625. doi: 10.1002/bimj.201500228. Epub 2016 May 17. Biom J. 2017. PMID: 27184938 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,449 results

Search Page

Filters